Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse.

Autor: von Eyben R; Department of Radiation Oncology, The Stanford University School of Medicine, Stanford, CA, USA., Hoffmann MA; Department of Occupational Health & Safety, Federal Ministry of Defense, Bonn, Germany; Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Kapp DS; Department of Radiation Oncology, The Stanford University School of Medicine, Stanford, CA, USA., Soydal C; Department of Nuclear Medicine, University of Ankara, Ankara, Turkey., Uprimny C; Department of Nuclear Medicine, University Hospital Innsbruck, Innsbruck, Austria., Virgolini I; Department of Nuclear Medicine, University Hospital Innsbruck, Innsbruck, Austria., Tuncel M; Department of Nuclear Medicine, Hacettepe University, Ankara, Turkey., Gauthé M; Department of Nuclear Medicine, Scintep, Institut Daniel Holland, Grenoble, France., von Eyben FE; Center of Tobacco Control Research, Odense, Denmark. Electronic address: finn113edler@mail.tele.dk.
Jazyk: angličtina
Zdroj: European urology oncology [Eur Urol Oncol] 2022 Dec; Vol. 5 (6), pp. 732-733. Date of Electronic Publication: 2022 Feb 05.
DOI: 10.1016/j.euo.2022.01.005
Databáze: MEDLINE